AI-ECG could catch deadly lung condition before It's too late

NCT ID NCT07079592

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) can detect pulmonary hypertension—a serious condition where blood pressure in the lungs is dangerously high—in people aged 50 to 85 who are at risk. Over 8,600 participants will get the AI-ECG screening; those flagged as high-risk will then receive an echocardiogram to confirm the diagnosis. The goal is to see if this approach leads to earlier detection and better heart and lung outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-ECG screening tool
What this could lead to
If successful, this AI-ECG could become a quick, low-cost way to screen for pulmonary hypertension, catching it earlier and improving outcomes.
What could go wrong
This is a large but early-stage validation study. The AI may not be accurate enough in real-world settings, and false positives or negatives could limit its usefulness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE (AI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Defense Medical Center

    RECRUITING

    Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.